Goodpasture's syndrome is a life threatening autoimmune kidney disease
. The patients have autoantibodies to the glomerular basement membrane
, which are specific for the C-terminal domain of type IV collagen (NC
1). The major antigen has been localized to the alpha 3(IV)-chain. We
have investigated sera from 44 patients with anti-NC1 antibodies. The
quantity of antibodies to four different alpha(IV)-chains of type IV c
ollagen was measured with direct ELISA. We used affinity chromatograph
y to separate the antibodies and their specificities were studied with
ELISA. The results show that about 1% of the patients total IgG are a
nti-NC1 antibodies and that 90% of these antibodies are specific for t
he alpha 3(IV)-chain. Antibodies to the other alpha(IV)-chains were fo
und in 80% of the patients. Furthermore, affinity purified anti-alpha
3(IV) antibodies from one patient were inhibited by antibodies from th
e other patients, from 4 to 72%. The antibodies, from 39 of the patien
ts, were inhibited by a monoclonal antibody against the alpha 3(IV)-ch
ain. The results indicate that patients with Goodpasture's syndrome ca
n have antibodies to most of the alpha(IV)-chains, while the majority
of anti-NC1 antibodies are restricted to the alpha 3(IV)-chain. Moreov
er the number of epitopes seems to be limited and the majority of the
antibodies from most patients are against one single epitope on the al
pha 3(IV)-chain.